Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
AMCIU Stock Summary
In the News
AMCI Acquisition Corp. II Announces Pricing of $150 Million Initial Public Offering
GREENWICH, Conn., Aug. 3, 2021 /PRNewswire/ -- AMCI Acquisition Corp. II (the "Company") today announced the pricing of its initial public offering of 15,000,000 units at a price of $10.00 per unit.
Asociación Colombiana de Medicina Crítica asesorará a Gobernación del Atlántico
Elsa Noguera manifestó que la asesoría será para la atención de pacientes afectados por el COVID-19 que estén en la ESE Cari de alta complejidad.
Worldwide Woodworking CNC Tools Market to 2029 - Featuring Robert Bosch Tool, Amana Tool & YASH Tooling System Among Others - ResearchAndMarkets.com
The
Packaging Foam Market With Thriving CAGR in Forecast Period 2020 to 2027
Jun 08, 2020 (Global QYResearch via COMTEX) -- There is certain pause to manufacturing activities across the globe due to COVID- 19 pandemic which is...
Automatic Guided Vehicle Market Registering a Strong Growth by 2020-2027
Jun 08, 2020 (Global QYResearch via COMTEX) -- There is certain pause to manufacturing activities across the globe due to COVID- 19 pandemic which is...
Camel Milk Market Size Analysis, Covid-19 Impact Analysis, Growth by Top Companies, Trends Forecasts Analysis to 2025
Jun 02, 2020 (The Expresswire) -- “Final Reports will add the analysis of the impact of COVID-19 on this industry” Global “Camel Milk market” forecast...
Length Gauges Market Size, Analysis 2020 Top Countries In-depth Research, Covid-19 Impact Analysis, Trends, Emerging Growth Factors and Regional Forecasts to 2025
Jun 01, 2020 (The Expresswire) -- “Final Reports will add the analysis of the impact of COVID-19 on this industry” Global “Length Gauges market” forecast...
Global Research report on Metal Conveyor Belts Market Size 2020 Analysis by Current Industry Status & Growth Opportunities, Top Key Players, Target Audience and Forecast to 2025
Jun 01, 2020 (The Expresswire) -- “Final Reports will add the analysis of the impact of COVID-19 on this industry” Global “Metal Conveyor Belts market”...
Piedmont Completes Additional Testwork to Produce High Grade Spodumene and Byproduct Concentrates | INN
Piedmont Lithium Limited is pleased to announce that it has produced 120 kg of spodumene concentrate from core samples collected from the Company’s Piedmont Lithium Project
Piedmont Completes Additional Testwork to Produce High Grade Spodumene and Byproduct Concentrates
Piedmont Lithium Limited (ASX:PLL; NASDAQ:PLL) (“Piedmont” or “Company”) is pleased to announce that it has produced 120 kg of spodumene concentrate f
AMCIU Financial details
AMCIU Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 11.26 | 13 | 17.56 | 0.36 | |
Net income per share | -42.34 | -42.59 | -54.1 | -0.76 | |
Operating cash flow per share | -24.1 | -21.74 | -0.16 | -0.55 | |
Free cash flow per share | -28.46 | -24.68 | -5.21 | -0.6 | |
Cash per share | 37.12 | 65.5 | 0 | 0.69 | |
Book value per share | 51.04 | 64.17 | 67.15 | 0.65 | |
Tangible book value per share | 51.04 | 64.17 | 67.15 | 0.65 | |
Share holders equity per share | 51.04 | 64.17 | 67.15 | 0.65 | |
Interest debt per share | 6.28 | 2.72 | 3.49 | 0.11 | |
Market cap | 16.14M | 18.93M | 21.22M | 885.4M | |
Enterprise value | -33.77M | -104.06M | 28.63M | 829.05M | |
P/E ratio | -0.23 | -0.23 | -0.18 | -6.6 | |
Price to sales ratio | 0.88 | 0.74 | 0.57 | 14.14 | |
POCF ratio | -0.41 | -0.44 | -61.38 | -9.1 | |
PFCF ratio | -0.35 | -0.39 | -1.92 | -8.36 | |
P/B Ratio | 0.19 | 0.15 | 0.15 | 7.73 | |
PTB ratio | 0.19 | 0.15 | 0.15 | 7.73 | |
EV to sales | -1.84 | -4.09 | 0.77 | 13.24 | |
Enterprise value over EBITDA | 0.92 | 2.2 | -0.4 | -8.21 | |
EV to operating cash flow | 0.86 | 2.44 | -82.8 | -8.52 | |
EV to free cash flow | 0.73 | 2.15 | -2.58 | -7.83 | |
Earnings yield | -4.28 | -4.41 | -5.42 | -0.15 | |
Free cash flow yield | -2.87 | -2.55 | -0.52 | -0.12 | |
Debt to equity | 0.13 | 0.04 | 0.05 | 0.17 | |
Debt to assets | 0.09 | 0.03 | 0.05 | 0.08 | |
Net debt to EBITDA | 1.36 | 2.6 | -0.1 | 0.56 | |
Current ratio | 5.04 | 3.02 | 0.03 | 6.22 | |
Interest coverage | 113.11 | 7.29K | 0 | 0 | |
Income quality | 1.04 | 0.91 | 0.25 | 0.73 | |
Dividend Yield | 0 | 7.95 | 0 | 0 | |
Payout ratio | 0 | -1.8 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0.16 | 0 | |
Research and developement to revenue | 1.88 | 1.74 | 1.42 | 1.09 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.18 | 0.14 | 31.05 | 0.09 | |
Capex to revenue | -0.39 | -0.23 | -0.29 | -0.14 | |
Capex to depreciation | -2.39 | -1.51 | -2.3 | -1.57 | |
Stock based compensation to revenue | 0.13 | 0.1 | 0.07 | 0.24 | |
Graham number | 220.51 | 247.98 | 285.89 | 3.34 | |
ROIC | -0.72 | -0.67 | -0.73 | -0.71 | |
Return on tangible assets | -0.58 | -0.43 | -0.75 | -0.55 | |
Graham Net | 21.15 | 37.47 | 6.89 | 0.15 | |
Working capital | 61.39M | 99.39M | -6.68M | 144.92M | |
Tangible asset value | 83.19M | 125.71M | 142.78M | 114.47M | |
Net current asset value | 40.8M | 81.38M | -9.52M | 45.55M | |
Invested capital | 0.13 | 0.04 | 0.05 | 0.17 | |
Average receivables | 0 | 13.14M | 22.14M | 34.55M | |
Average payables | 0 | 1.8M | 2.47M | 3.28M | |
Average inventory | 0 | 2.43M | 3.53M | 4.75M | |
Days sales outstanding | 232.83 | 208.99 | 290.25 | 229.59 | |
Days payables outstanding | 36.12 | 58.58 | 32.19 | 29.38 | |
Days of inventory on hand | 61.46 | 69.51 | 53.73 | 38.69 | |
Receivables turnover | 1.57 | 1.75 | 1.26 | 1.59 | |
Payables turnover | 10.11 | 6.23 | 11.34 | 12.42 | |
Inventory turnover | 5.94 | 5.25 | 6.79 | 9.44 | |
ROE | -0.83 | -0.66 | -0.81 | -1.17 | |
Capex per share | -4.36 | -2.94 | -5.05 | -0.05 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | -11.83 | 0.08 | 0.07 | 0.1 | 0.1 | |
Net income per share | -14.28 | -0.58 | -0.14 | -0.13 | -0.09 | |
Operating cash flow per share | 32.56 | -0.29 | -0.13 | -0.11 | -0.08 | |
Free cash flow per share | 30.64 | -0.3 | -0.15 | -0.12 | -0.09 | |
Cash per share | 0 | 1.67 | 0.82 | 0.65 | 0.62 | |
Book value per share | 65.5 | 1.97 | 1.08 | 0.66 | 0.58 | |
Tangible book value per share | 65.5 | 1.97 | 1.08 | 0.66 | 0.58 | |
Share holders equity per share | 65.5 | 1.97 | 1.08 | 0.66 | 0.58 | |
Interest debt per share | 3.4 | 0.06 | 0.04 | 0.04 | 0.1 | |
Market cap | 21.76M | 452.14M | 1.34B | 914.71M | 989.11M | |
Enterprise value | 29.16M | 313.77M | 1.23B | 830.51M | 932.77M | |
P/E ratio | -0.17 | -1.68 | -12.46 | -9.03 | -13.24 | |
Price to sales ratio | -0.84 | 46.87 | 103.39 | 46.66 | 48.34 | |
POCF ratio | 0.31 | -13.37 | -52.77 | -40.75 | -62.88 | |
PFCF ratio | 0.33 | -12.85 | -45.65 | -37.69 | -57.68 | |
P/B Ratio | 0.15 | 1.97 | 6.31 | 7.12 | 8.64 | |
PTB ratio | 0.15 | 1.97 | 6.31 | 7.12 | 8.64 | |
EV to sales | -1.13 | 32.53 | 95.39 | 42.36 | 45.58 | |
Enterprise value over EBITDA | -1.61 | -10.04 | -42.1 | -35.77 | -54.31 | |
EV to operating cash flow | 0.41 | -9.28 | -48.69 | -37 | -59.29 | |
EV to free cash flow | 0.44 | -8.92 | -42.12 | -34.22 | -54.4 | |
Earnings yield | -1.43 | -0.15 | -0.02 | -0.03 | -0.02 | |
Free cash flow yield | 3.07 | -0.08 | -0.02 | -0.03 | -0.02 | |
Debt to equity | 0.05 | 0.03 | 0.03 | 0.06 | 0.17 | |
Debt to assets | 0.05 | 0.02 | 0.02 | 0.03 | 0.08 | |
Net debt to EBITDA | -0.41 | 4.43 | 3.53 | 3.63 | 3.28 | |
Current ratio | 0.03 | 7.06 | 6.41 | 5.26 | 6.22 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 1.32 | 0.53 | 0.94 | 0.89 | 0.84 | |
Dividend Yield | 0 | 0.47 | 0 | 0 | 0 | |
Payout ratio | 0 | -3.16 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | -0.52 | 1.69 | 1.46 | 0.85 | 0.8 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.06 | 0.04 | 0.16 | 0.08 | 0.09 | |
Capex to revenue | 0.16 | -0.14 | -0.31 | -0.09 | -0.07 | |
Capex to depreciation | -3.43 | -1.09 | -2.93 | -1.32 | -0.96 | |
Stock based compensation to revenue | -0.02 | 0.36 | 0.4 | 0.16 | 0.16 | |
Graham number | 145.06 | 5.07 | 1.83 | 1.38 | 1.12 | |
ROIC | -0.12 | -0.14 | -0.14 | -0.17 | -0.14 | |
Return on tangible assets | -0.2 | -0.22 | -0.09 | -0.1 | -0.08 | |
Graham Net | 6.72 | 1.18 | 0.47 | 0.18 | 0.13 | |
Working capital | -6.68M | 206.57M | 176.3M | 143.74M | 144.92M | |
Tangible asset value | 142.78M | 229.81M | 211.64M | 128.48M | 114.47M | |
Net current asset value | -9.52M | 162.5M | 118.22M | 59.61M | 45.55M | |
Invested capital | 0.05 | 0.03 | 0.03 | 0.06 | 0.17 | |
Average receivables | 28.07M | 28.72M | 28.64M | 31.97M | 36.9M | |
Average payables | 1.99M | 7.01M | 11.34M | 8.47M | 4.92M | |
Average inventory | 2.08M | 2.42M | 669K | 671.5K | 3.01M | |
Days sales outstanding | -103.66 | 258.79 | 205.84 | 157.91 | 173.27 | |
Days payables outstanding | 24.8 | 133.12 | 92.71 | 36.19 | 27.14 | |
Days of inventory on hand | 41.38 | 7.72 | 5.57 | 4.21 | 35.73 | |
Receivables turnover | -0.87 | 0.35 | 0.44 | 0.57 | 0.52 | |
Payables turnover | 3.63 | 0.68 | 0.97 | 2.49 | 3.32 | |
Inventory turnover | 2.17 | 11.66 | 16.16 | 21.35 | 2.52 | |
ROE | -0.22 | -0.29 | -0.13 | -0.2 | -0.16 | |
Capex per share | -1.93 | -0.01 | -0.02 | -0.01 | -0.01 |
AMCIU Frequently Asked Questions
What is AMCI Acquisition Corp. II stock symbol ?
AMCI Acquisition Corp. II is a US stock , located in Greenwich of Ct and trading under the symbol AMCIU
What is AMCI Acquisition Corp. II stock quote today ?
AMCI Acquisition Corp. II stock price is $- today.
Is AMCI Acquisition Corp. II stock public?
Yes, AMCI Acquisition Corp. II is a publicly traded company.